ASCO® 2024 Insights: "ETOP 13-18 BEAT-meso Trial - Bevacizumab + Chemo +/- Atezolizumab as 1L Treatment for Advanced Pleural Mesothelioma" | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ETOP 13-18 BEAT-meso Trial - Bevacizumab + Chemo +/- Atezolizumab as 1L Treatment for Advanced Pleural Mesothelioma"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Sanjay Popat

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Sanjay Popat

99 views

June 17, 2024

Comments 0

Login to view comments. Click here to Login